chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Approximately 5 minutes after receiving vaccine her right eye became blurry.  No other symptoms.  No headache.  BP 137/82 Pulse 92.  Within 5 more minutes her right eye went dark.  She was taken to ED.  They did a CT scan and diagnosed her with ocular migraine.  She was given benadryl, compazine and IV fluids.  Symptoms resolved.
mild body ache; Jointpain; Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 50-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the arm left on 16Mar2021(at the age of 50-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247) via an unspecified route of administration on 23Feb2021 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date in Mar2021 after taking second dose, the patient experienced mild body ache, Joint pain, fatigue. The clinical outcome of the events mild body ache, Joint pain, fatigue were recovered.   No follow-up attempts are possible. No further information is expected.
This is a spontaneous report from a contactable consumer (patient). A 37-year-old (non-pregnant) female patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EN6205), at the age of 37, via an unspecified route of administration, left arm, on Mar 30, 2021, at 17:30, single dose, for COVID-19 immunisation. Medical history not reported. The patient has no allergies to medications, food or other products. Prior to the vaccination, patient was not diagnosed with COVID-19. Concomitant medications included Contrave (naltrexone hydrochloride/bupropion hydrochloride), for an unknown indication; from an unknown date. Previously, patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# EN6202), at the age of 37, via an unspecified route of administration, left arm, on Mar 9, 2021, at 16:30, single dose, for COVID-19 immunisation. The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccine. On Apr 2, 2021, at 10:00, patient reported the Friday after receiving the second dose of the Pfizer COVID-19 vaccine, she broke-out in hives. The patient never had hives in her life. The only new thing she encountered recently was the vaccine. Therapeutic measures taken as a result of hives included treatment with Benadryl.  Since the vaccination, patient has not tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event hives: not recovered (at the time of this report). No follow-up attempts needed. No further information expected.
Cheat pain?substernal pain radiating to back of chest, chest tightening and feeling of sandpaper scratching behind sternum   Shortness of breath?both at rest and upon exertion   Tachycardia?at rest, measured at 130 BPM  Syncope/ feeling of faintness  All occurred at the same time, chest pain still present 24 hours post vaccine
I thought I had a blemish on the left side of my face. But it started hurting very badly. I put my finger on it and pushed to help relieve the pain. And then there was a shooting pain/shock sensation from it to my cheek. Then the left side of my face went numb, plus had tingling, and some shooting pain. This has now been going on 24/7 since.
I have inflammatory arthritis symptoms in my hands and feet. I noticed it on day 3 but it could've been present before. I have swelling in the small joints in my hands and feet. My hands are swollen to a point where I cant wear my normal rings. I went to the dr and has tests ran. He thinks this might be the first flare of lupus. I went on Plaquenil about a month after it started. It is unclear whether it has helped. I take 200mg 2x a day. I am considering going on methotrexate but am just waiting on blood work. I've had other joint problems but never to this extreme.
warm feeling all over; Fatigue; body aches; nausea; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (warm feeling all over), FATIGUE (Fatigue), MYALGIA (body aches) and NAUSEA (nausea) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027B21A and 031A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Apr-2021, the patient experienced FEELING HOT (warm feeling all over), FATIGUE (Fatigue), MYALGIA (body aches) and NAUSEA (nausea). At the time of the report, FEELING HOT (warm feeling all over), FATIGUE (Fatigue), MYALGIA (body aches) and NAUSEA (nausea) outcome was unknown.            No concomitants were reported. No treatment was reported. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (unknown) was not applicable.
fitful sleep; waking up with sweat; nausea; chills; low grade fever; hurting joints; headache; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (fitful sleep), HYPERHIDROSIS (waking up with sweat), NAUSEA (nausea), CHILLS (chills) and PYREXIA (low grade fever) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Asthma and Urticaria. Concurrent medical conditions included Drug allergy (Keflex), Drug allergy (tetracycline) and Heart disorder since 06-Apr-2014. Concomitant products included APIXABAN (ELIQUIS) from 15-Apr-2014 to an unknown date for Atrial fibrillation, METOPROLOL from 15-Apr-2014 to an unknown date for Heart disorder, LEVOTHYROXINE from 15-May-1986 to an unknown date for Thyroid disorder.    On 26-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Oct-2021, the patient experienced INSOMNIA (fitful sleep), HYPERHIDROSIS (waking up with sweat), NAUSEA (nausea), CHILLS (chills), PYREXIA (low grade fever), ARTHRALGIA (hurting joints) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) on 27-Oct-2021 for Low grade fever, at a dose of 2 Tab 2 times. On 28-Oct-2021, INSOMNIA (fitful sleep), HYPERHIDROSIS (waking up with sweat), NAUSEA (nausea), CHILLS (chills), PYREXIA (low grade fever), ARTHRALGIA (hurting joints) and HEADACHE (headache) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102 (High) increased body temperature 102.         This case was linked to MOD-2021-355552 (Patient Link).
Cranky, ornery, misbehaved, violent throwing behavior, screaming almost steady bouncing off walls; no apparent fever, no sleep for 24hrs period;
Patient presents with a potential reaction to the COVID19 vaccine. I was called to the patient's car outside of the vaccination area at the traffic circle for a report of a patient not breathing. Upon arrival, the patient was responsive, but minimally. She was pale and diaphoretic. The patient was placed in the supine position with legs up. Her airway was open. There was no sign of systemic allergic reaction of anaphylaxis. Rather, presentation was consistent with a severe vasovagal episode with syncope. EMS was summoned. The patient's pulse, BP and SpO2 were WNL on initial exam. The patient was moved back to the monitoring area. Over time, the patient became more responsive, however, began to have significant emesis on multiple occasions. She was not able to tolerate oral hydration. SL Zofran 4mg was given via EMS. Emesis abated. The patient was moved to the stretcher in the ambulance. A peripheral IV was started and 1000ml NS was given. BG was 121. Patient's level of consciousness improved, however, emesis remained profuse and dark in color.  Plan: Patient presented with a severe vasovagal episode with subsequent severe emesis with an inability to tolerate PO fluids. Despite SL Zofran and 1000ml of NS, symptoms didn't improve. As such, patient was transferred via EMS to the ED.
I had sinus congestive, running nose, slight SOB, fatigue and slight cough. These lasted for 4 days. On Jan 7th, I tested positive for Covid-19.
Pt stated that her left arm began to ache throughout the day and continue to worsen over the next few days.
flu; Initial information was received on 06-Dec-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-health-care professional.  This case involves Adult and unknown gender patient who experienced flu after receiving vaccine influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  In October 2022, the patient received a dose of suspect influenza vaccine produced by unknown manufacturer (with lot number, pharmaceutical form, strength, dose not reported) via unknown route in unknown administration site for prophylaxis.  On an unknown date the patient developed a non-serious event of flu (influenza) (unknown latency) following the administration of influenza vaccine.  Action taken : Not Applicable.  It was not reported if the patient received a corrective treatment for the event (flu).  At time of reporting, the outcome was Unknown for the event flu.
fractured her foot; Caller fell and fractured her foot; This spontaneous case was reported by a consumer and describes the occurrence of FOOT FRACTURE (fractured her foot) and FALL (Caller fell and fractured her foot) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included QUETIAPINE FUMARATE (SEROQUEL), ROPINIROLE HYDROCHLORIDE (REQUIP), OXYBUTYNIN, ALPRAZOLAM (XANAX), PREDNISONE and ESCITALOPRAM OXALATE (LEXAPRO) for an unknown indication.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, the patient experienced FOOT FRACTURE (fractured her foot) and FALL (Caller fell and fractured her foot). At the time of the report, FOOT FRACTURE (fractured her foot) had not resolved and FALL (Caller fell and fractured her foot) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: no new information
Information has been received from a physician concerning a 21 year old female patient who on 30-JUN-2009 was vaccinated IM with the first 0.5 mL dose of GARDASIL. On 30-JUN-2009, after receiving GARDASIL, the patient got up to vomit, fainted and hit her head on the bathroom door. The patient was taken to the emergency room, received 8 stitches above her right eyebrow, and was released on the same day. The patient's final outcome was not reported. Additional information has been requested.
Headache, Myalgia, Rash, NauseaVomiting, fatigue Narrative:  headache Dec 29-31, swelling and redness at site without pain started Jan 1 to current, fatigue Jan 1 to current, headache resumed Jan 3 to current, mild morning nausea starting Jan 4 to current, body aches Jan 4 to current mostly in ankles, knees and low back. Note she is also reporting directly to CDC herself
Evening of vaccine pt developed sx of depression that worsened for 1 week to include suicidal thoughts.
Site: Redness at Injection Site-Mild, Additional Details: patient checked in for a vaccine for flu and pharmacist confirmed flu shot but she said she was not suppose to get the flu she wanted covid she called 12/20/22 2:30pm she said she already recieved the flu shot after researching her she has 2 profiles there is a profile with her name spelled incorrectly which had her covid shot on hold. The patient says she feels completely fine no side effects at all and still wants her covid booster. She was advised to come 2 weeks from 12/15/22
A non-serious spontaneous report of "H1N1 given to a 58 year old" was received from a registered nurse/health professional concerning a 58-year-old male patient. No relevant medical history have been reported for this patient. On 13-Nov-2009, the patient received H1N1, Intranasal. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments were not applicable, and the event was considered as resolved.
Case number PHEH2014US021090, is an initial spontaneous report from a physician received on 17 OCT 2014. This report refers to a 3 years and 4 months old male patient. His medical history and concomitant medications were not reported. On 16 OCT 2014, the patient inadvertently received an intramuscular dose of FLUVIRIN 2014/2015 (batch number: 1464603). No adverse event was reported following this medication error (inappropriate age at vaccine administration).
severe left side of face swelling, throat felt like it was closing, nausea, left arm sore
Her arm has developed a hot, swollen, red area where the injection was given. It started as a knot 3 days ago and has become worse over the last few days. She has called her PCP so that they can follow up on this. She is planning on getting an appointment with her PCP
01/27/22 presents to EC ED for "nausea, vomiting, and abdominal pain". "COVID on 1/20/21" "no significant PMH"
Tremor became very noticable in Aug 2021,  saw pcp and neurologist.  No diagonsis made
Patient reported that 2 weeks after her second dose of Moderna, she experienced drooping of the face on the left side. Patient reported that she went to the emergency room and they prescribed her benadryl and dexamethasone. Patient reported that symptoms resolved within 24 hours. No permanent damage reported.
I woke up at 11:30 and was hallucinating and very angry and violent.  I was  extremely red in my face could of had a temperature.  I was yelling at my wife and children.  This is very out of character for me and woke up this morning and had trouble recalling all the events of the previous night until my wife informed me of them.
I had some irritation at the injection site but I did with all previous and if went away... I started having dizzy spells about 8 days later. This progressed to severe dizziness, vertigo after 10 days to now (Feb 4). I went to Urgent Care on Feb 2 and received Meclizine, Cetirizine, and Fluticasone Propionate nasal spray scripts and started using late that afternoon?I feel somewhat better today but still persistent dizziness?  I did have covid in Sept of 2022 and was prescribed Paxlovid as a precaution. My symptoms were mild and recovered fully with no lingering symptoms.
Approximately 10 minutes after injection, began feeling aching pain over entire body especially back and joint areas. Had difficulty walking and moving extremities. Waited about 10 minutes and pain subsided to milder pain. Pain slowly went away except for pain at injection site, which is still sore today.
Patient had an allergic reaction at night, she had throat swelling and itching She went to ER she was treated with PEPCID, BENADRYL and SOLU-MEDROL but SOLU-MEDROL did not help. Dr. gave her EPIPEN.
This spontaneous report was received from a pharmacy student regarding an approximately 63 years old female patient. On 12-NOV-2012, the patient was vaccinated with a dose of ZOSTAVAX (lot# reported as H013943, expiry: 25-OCT-2013) route an dose not reported. No concomitant medications were reported. On 12-NOV-2012, the patient developed a red, itchy area around the injection site. Patient sought medical attention(contacted pharmacy). Patient was treated with triamcinolone cream. The outcome of red, itchy area around the injection site was reported as not recovered. Additional information is not expected.
Patient experienced extreme itching as soon as ZOSTAVAX vaccine was administered. Patient noticed a large welt at injection site two days later. Patient was instructed to ice the affected arm and take BENADRYL to decrease itching.
This spontaneous report as received from a health care worker refers to an unspecified number of patients of unknown age and gender. On an unknown date in 2015 (reported as during the month of February 2015 vaccine exposed to 48 F) the patients were vaccinated with GARDASIL (dose, lot number was unknown) which was improperly stored, exposed to 48 F for 26 days during the month of February 2015. No adverse effects were reported. No product quality complaint (PQC) was involved. The outcome of the event was unknown. No further information was provided. This case is linked several cases with the same reporter link. Additional information has been requested.
This spontaneous report as received from a medical assistant refers to an unspecified number of patients of unknown age and gender. The patients were vaccinated with a dose of VAQTA (lot number not specified). Route was unknown). The reporter stated that up to 10 patients had received improperly stored vaccines during the time period of 17-SEP-2012 through 02-OCT-2012. Vaccines involved were MMR II, VAQTA, RECOMBIVAX HB and GARDASIL. No symptoms were reported. This is one of multiple reports from the same source (other case IDs 1210USA005704, 1210USA009229 and 1210USA009231). Additional information has been requested.
Patient got diagnosed with COVID-19 within 24 hours of receiving first dose and was admitted to the hopistal and died on 08/11/2021
SUSPECTED COVID-19 INFECTION(FEVERISH NIGHT SWEATS, SWEATING OUT MY FEET, AND FEEL NAUSEOUS); This spontaneous report received from a patient concerned a patient of unspecified age and sex.  The patient's height, and weight were not reported. The patient's concurrent conditions included: Crohn's disease, enteropathic arthritis, asthma, and drug allergy (Patient had drug allergy of Remicade (infliximab), lmuran (azathioprine), Humira (adalimumab)). The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 02-JUN-2020 for covid-19 prophylaxis. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. Concomitant medications included budesonide/formoterol fumarate, famotidine, paracetamol, salbutamol, and valaciclovir hydrochloride. On 04-JUL-2022, the patient experienced suspected covid-19 infection (feverish night sweats, sweating out my feet, and feel nauseous). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from suspected covid-19 infection (feverish night sweats, sweating out my feet, and feel nauseous). This report was non-serious.
Systemic: Patient compliant of numbness of the left face side starting about 3 to 4 hours after vaccine-Medium
migraine , blurry vision,drop foot,leg pain, Concentration problems, numbness, weakness, all still effecting me
A non-serious report of expired FLUMIST given was received from a registered nurse concerning a 29-year-old male.  On 04-Dec-2008, the patient was administered expired FLUMIST (12-Nov-2008);  the product was expired by 22 days.  The reporter indicated the FLUMIST expired at the beginning of the flu season.  There was no adverse event associated with this event;  therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved.  Based on the results of the investigation, the root cause for the medication errors were caused by 1) customers not discarding product from the previous season and 2) product expiring during the peak of the flu season resulting in some medication errors that occurred shortly after the product expired.  Additional information received on 09-Apr-2009:  product complaint investigation results.
Pt developed pain, swelling redness 9cm x 9cm area R deltoid and decrease ROM of R arm.
This spontaneous report as received from a health care worker refers to 3 patients of unknown age and gender. On an unknown date the 3 patients were vaccinated with GARDASIL, 0.5 ml, intramuscular. The GARDASIL administered were exposed to temperature conditions that Merck cannot support. No adverse effects reported. Additional information has been requested.
Morning after vaccination, patient woke up feeling very weak and nauseated for the entire day. One episode of vomiting in the morning. Diarrhea later in the day. By the following day, the patient's symptoms had subsided.
Received  second shot on April 2@ 1130am. Started with diarhhea  and vomiting's on April 6 at 3:30 am. Continued to 4:30 am on April 10. Slight elevated temperature at 99.1 .  On morning of April 11 couldn't put pressure on right side, leg and arm, facial numbness. Went to er and they said I was having a stoke, transferred to hospital. MRI done verified Stroke with blood clot to Left thalamus Sent home and will be receiving PT and OT.
pt recvd vax & devel n; fever; sweats; fatigue; exhaustion; poor coordination; diarrhea w/in 24 hrs,lasted 24 hrs; resolved & reoccured for 24 hrs more; ache at inject site;
excessive heart beating began after about 1 hour since had been vaccinated nausea - still continuing as of morning of 3/19 with every food consumption, cannot hold food spontaneous fever, mostly in the evenings numbness and soreness in left arm within first two days
Bruise and pain at injection site 1 week post vaccination. Patient also reports blurry vision in right eye.
Sudden onset of severe tinnitus that is described as a constant high pitched ringing noise in both ears. Patient has never experienced tinnitus prior to receiving the vaccine.
pt recvd vax & devel fever & vomiting 1st 48-72 hrs of vax; left arm inject site was red, warm, swollen, & painful; had hypersensitivity to vax; to MD;
1STEMI involving right coronary artery, stent placed. ED visit to hospital admission within 6 weeks of receiving the COVID vaccine.
Patient administered Pfizer mRNA on 9/26/22 and 10/17/22 after previously receiving JNJ x1 in 2/2022
WBC count has gone up; via subcutaneous; This is a spontaneous report from a contactable consumer reported for himself. This 75-year-old male patient received the 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via subcutaneous on 17Feb2021 at single dose for COVID-19 immunisation. Medical history included prostrate operation 11 years ago, psoriasis and hypertension which was controlled. The patient did not have any blood disorders. Concomitant medications were unknown. The patient had his second dose of the pfizer Covid 19 vaccine on 17Feb2021. and something that had never happened to him before, he had 3 blood test and on all 3 his WBC count had gone up since the Pfizer vaccine dose. The patient asked if the vaccine caused this. He had asked his doctor but he was not able to answer the question. Outcome of the event was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.